Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation (NCT05535738) | Clinical Trial Compass
RecruitingPhase 2/3
Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation
United States45 participantsStarted 2022-11-15
Plain-language summary
The purpose of this study is to answer: how do inflammation and anti-inflammatory skin therapies work in the skin? Inflammation is a protective response from the body's immune system to injury, disease, or irritation. It is a process by which your body's white blood cells and the things they make protect you from infection from outside invaders such as bacteria and viruses.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Healthy adult subjects over the age of 18 years with no skin diseases
* Patients with dermatologic conditions such as atopic dermatitis, history of localized non-melanoma, keratinocytic skin cancer
* Patients with previous clinical patch testing
* UMass Medical School students and employees are eligible to participate.
* Non-English-speaking individuals are also eligible with the assistance of an interpreter and an approved short form consent in the appropriate language.
Exclusion Criteria:
* Adults unable to give consent
* History of the following specific dermatologic conditions (which would be confounders due to their particular immunologic etiologies, specifically the TNFa and IL-17 pathways which oppose the Th2 pathway): pityriasis rubra pilaris and psoriasis
* Patients actively receiving whole body phototherapy
* Patients actively receiving systemic broad-spectrum immunosuppression (prednisone, mycophenolate mofetil, azathioprine, methotrexate)
* Any history of poor wound healing
* History of uncontrolled diabetes
* History of easily torn skin
* Any known cardiac arrhythmia or history of heart failure
* History of demyelinating disease
* History of liver disease or alcohol abuse
* History of melanoma
* Pregnant women
* Individuals who are high risk for tuberculosis including prisoners, immigrants from TB- endemic areas, or US-based travelers who have visited TB-endemic areas
* Individuals with a self-reported personal history of infection with l…
What they're measuring
1
To collect and evaluate single-cell multiomics data (RNAseq, CITEseq, TCRseq)